本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Maravai LifeSciences Holdings, Inc.

2.75
+0.05001.85%
盘后2.750.00000.00%18:41 EDT
成交量:116.57万
成交额:320.44万
市值:7.02亿
市盈率:-2.04
高:2.80
开:2.72
低:2.66
收:2.70
52周最高:8.99
52周最低:1.67
股本:2.55亿
流通股本:1.45亿
量比:0.68
换手率:0.81%
股息:- -
股息率:- -
每股收益(TTM):-1.3483
每股收益(LYR):-1.0503
净资产收益率:-54.84%
总资产收益率:-5.89%
市净率:2.64
市盈率(LYR):-2.62

数据加载中...

公司资料

公司名字:
Maravai LifeSciences Holdings, Inc.
交易所:
NASDAQ
成立时间:
2014
员工人数:
560
公司地址:
10770 Wateridge Circle,Suite 200,San Diego,California,United States
邮编:
92121
电话:
传真:
- -
简介:
Maravai Lifesciences Holdings, Inc.于2020年8月25日在特拉华州注册成立。该公司是一家领先的生命科学公司,提供关键产品,以支持药物疗法,诊断学,新型疫苗的开发以及对人类疾病的支持研究。

董事

名称
职位
Bernd Brust
Director and Chief Executive Officer
Robert Andrew Eckert
Chairman of the Board
Gregory T. Lucier
Independent Director
Jessica Hopfield
Independent Director
John A. DeFord
Independent Director
Murali K. Prahalad
Independent Director
Susannah Gray
Independent Director
Benjamin Daverman
Director
Constantine Mihas
Director
Luke Marker
Director
Sean Cunningham
Director

股东

名称
职位
Bernd Brust
Director and Chief Executive Officer
Rajesh J. Asarpota
Chief Financial Officer
Christine Dolan
Executive Vice President and General Manager, Cygnus Technologies
Kevin Herde
Principal Accounting Officer
Kurt Oreshack
General Counsel and Secretary